Monocyte News and Research

RSS
Severe and necrotizing AP characterized by depletion of circulating lymphocytes

Severe and necrotizing AP characterized by depletion of circulating lymphocytes

Even modest weight loss brings many health benefits

Even modest weight loss brings many health benefits

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

PS-targeting antibodies can block HIV virus from entering into certain blood cells

PS-targeting antibodies can block HIV virus from entering into certain blood cells

Peregrine's PS-targeting antibodies block HIV from entry into blood cells

Peregrine's PS-targeting antibodies block HIV from entry into blood cells

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx undertakes Phase II clinical trial of CCX140

Promedior raises $12M in Series C financing

Promedior raises $12M in Series C financing

Investigators develop new mathematical approach to analyze molecular data

Investigators develop new mathematical approach to analyze molecular data

Scientists devise software algorithm to detect medically useful information from whole-blood samples

Scientists devise software algorithm to detect medically useful information from whole-blood samples

TLR's role in HIV-1 reactivation induced by periodontal pathogens

TLR's role in HIV-1 reactivation induced by periodontal pathogens

Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential

Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential

α-defensins1-3 may be potential prophylactic agents in treatment of HIV / AIDS

α-defensins1-3 may be potential prophylactic agents in treatment of HIV / AIDS

New treatments for heart disease

New treatments for heart disease

Study on the role of MCP-1 in obese patients with pancreatic cancer

Study on the role of MCP-1 in obese patients with pancreatic cancer

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

ChemoCentryx commences enrollment in CCX354 Phase 2 clinical trial for RA

ChemoCentryx commences enrollment in CCX354 Phase 2 clinical trial for RA

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

Clinical trials of personalised vaccines to fight glioblastomas

Clinical trials of personalised vaccines to fight glioblastomas

Experts to study how olive oil lowers the level of cytotoxicity in endothelial cells

Experts to study how olive oil lowers the level of cytotoxicity in endothelial cells

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity